Vs3
10 employees on LinkedIn · 3 known investors
VS3 Medical is a medical device company developing the VS3 Medical Stent System, an investigational neurovascular implant designed to treat symptomatic venous sinus stenosis within the dural venous sinus anatomy. The device is not yet available for sale and is undergoing first-in-human clinical study.
Investors · 3
Competitors · 5
by search overlapCtrip (NASDAQ: TCOM）5 shared keywordsTrip.com is an international online travel service provider offering hotel and flight bookings across a network of over 1.7 million hotels and 600+ airlines, available in 24 languages and 35 currencies across 39 countries and regions. It provides multilingual customer support to travelers worldwide.
Flightstats5 shared keywordsFlightStats provides flight tracking and day-of-travel information for travelers, including free and subscription-based tools for monitoring flights. The site publishes on-time performance reviews for airlines and airports, in association with Cirium.
Verse Medical5 shared keywordsVerse Medical builds software to coordinate home-based healthcare services, replacing fragmented vendor interactions and outdated communication methods with a unified platform for in-home care providers.
Docus4 shared keywordsDocus provides an AI layer for diagnostic labs, offering clinical interpretation reports, follow-up recommendations, compliance validation, digital requisitions, and context-aware AI assistants for doctors and patients. It serves direct-to-consumer, reference, and in-house/clinic labs with integration via API/HL7 or its own interfaces.
Viasat4 shared keywordsViasat provides residential satellite internet service, offering broadband plans with tiered high-speed data for home customers. It operates as a satellite communications and internet service provider.
Companies competing with Vs3 for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Vs3 do?
- VS3 Medical is a medical device company developing the VS3 Medical Stent System, an investigational neurovascular implant designed to treat symptomatic venous sinus stenosis within the dural venous sinus anatomy. The device is not yet available for sale and is undergoing first-in-human clinical study.
- Who are Vs3's investors?
- Vs3's investors include APERTURE Venture Partners, Gilde Healthcare, US Venture Partners.